Table 5:
OS based on 7th edition TNM | |||
---|---|---|---|
Stage | p-Value | HR | 95% CI |
IA vs. IB | <0.001 | 0.61 | 0.51–0.73 |
IB vs. IIA | <0.001 | 0.41 | 0.31–0.54 |
IIA vs. IIB | <0.001 | 0.27 | 0.20–0.38 |
IIB vs. IIIA | <0.001 | 0.24 | 0.17–0.34 |
IIIA vs. IIIB | <0.001 | 0.39 | 0.27–0.57 |
OS based on 8th edition TNM | |||
IA1 vs. 1A2 | 0.004 | 0.42 | 0.24–0.75 |
IA2 vs. IA3 | <0.001 | 0.34 | 0.20–0.59 |
IA3 vs. IB | <0.001 | 0.29 | 0.17–0.48 |
IB vs. IIA | <0.001 | 0.22 | 0.14–0.36 |
IIA vs. IIB | <0.001 | 0.22 | 0.15–0.33 |
IIB vs. IIIA | <0.001 | 0.20 | 0.14–0.27 |
IIIA vs. IIIB | <0.001 | 0.33 | 0.26–0.42 |
DFS based on 7th edition TNM | |||
IA vs. IB | <0.001 | 0.66 | 0.56–0.78 |
IB vs. IIA | <0.001 | 0.46 | 0.36–0.59 |
IIA vs. IIB | <0.001 | 0.31 | 0.23–0.42 |
IIB vs. IIIA | <0.001 | 0.30 | 0.21–0.42 |
IIIA vs. IIIB | <0.001 | 0.46 | 0.32–0.66 |
DFS based on 8th edition TNM | |||
IA1 vs. 1A2 | 0.015 | 0.55 | 0.34–0.89 |
IA2 vs. IA3 | <0.001 | 0.44 | 0.28–0.70 |
IA3 vs. IB | <0.001 | 0.39 | 0.25–0.61 |
IB vs. IIA | <0.001 | 0.30 | 0.20–0.46 |
IIA vs. IIB | <0.001 | 0.29 | 0.20–0.41 |
IIB vs. IIIA | <0.001 | 0.25 | 0.19–0.34 |
IIIA vs. IIIB | <0.001 | 0.39 | 0.31–0.48 |
OS = overall survival; DFS = disease free survival; HR = hazard ratio; CI = confidence interval.